Antimicrobial Resistance is the $860Bn problem killing 5 million people which is not going away. It impacts human and animal health. Oppilotech are developing first-in-class antibacterial therapies through using AI to build and model bacteria. The company is currently sequencing the genome of over 20,000 bacteria to build the models.